Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients (vol 88, pg 251, 1998)

被引:0
|
作者
Wessels, F
机构
来源
SOUTH AFRICAN MEDICAL JOURNAL | 1998年 / 88卷 / 04期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:471 / 471
页数:1
相关论文
共 50 条
  • [21] Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia
    Borja, J
    Jané, F
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) : 436 - 436
  • [22] Cost-effectiveness analysis of alternative antimicrobial treatments for community-acquired pneumonia (CAP)
    Martin, M
    Quilici, S
    Garau, J
    File, TM
    Kubin, M
    VALUE IN HEALTH, 2005, 8 (06) : A56 - A57
  • [23] Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia
    Zervos, M
    Nelson, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) : 729 - 733
  • [24] Delafloxacin for the treatment of adult patients with community-acquired bacterial pneumonia
    Bassetti, Matteo
    Melchio, Monica
    Giacobbe, Daniele Roberto
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (05) : 649 - 656
  • [25] Comparative Effectiveness of Ceftriaxone in Combination With a Macrolide Compared With Ceftriaxone Alone for Pediatric Patients Hospitalized With Community-acquired Pneumonia
    Leyenaar, JoAnna K.
    Shieh, Meng-Shiou
    Lagu, Tara
    Pekow, Penelope S.
    Lindenauer, Peter K.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (04) : 387 - 392
  • [26] Community-Acquired Pneumonia: Treatment at Home or in the Hospital?
    Aujesky, Drahomir
    Fine, Michael J.
    AMERICAN JOURNAL OF MEDICINE, 2008, 121 (12): : 1038 - 1040
  • [27] The cost of treating patients with community-acquired pneumonia
    Lave, JR
    Lin, CCJ
    Fine, MJ
    Hughes-Cromwick, P
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 20 (03) : 189 - 197
  • [28] A Cost-Effectiveness Analysis of Obtaining Blood Cultures in Children Hospitalized for Community-Acquired Pneumonia
    Andrews, Annie Lintzenich
    Simpson, Annie N.
    Heine, Daniel
    Teufel, Ronald J., II
    JOURNAL OF PEDIATRICS, 2015, 167 (06): : 1280 - 1286
  • [29] The cost-effectiveness of drug therapy in community-acquired pneumonia and the impact of antimicrobial resistance in Germany
    Martin, M.
    Quilici, S.
    Evers, T.
    Kubin, M.
    VALUE IN HEALTH, 2006, 9 (06) : A261 - A261
  • [30] Cost-Effectiveness Analysis between Rocephin and Ceftrixone in Hospitalized Patient with Community-Acquired Pneumonia
    Chao, Min-Hsin
    Lin, Shun-Jin
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 476 - 476